Trinity Biotech has acquired 3 companies. A total of 2 acquisitions came from private equity firms.
Trinity Biotech’s largest acquisition to date was in 2013, when it acquired IMMCO Diagnostics for $33M. Trinity Biotech has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include medical products (67%) and life science (34%).
Join Mergr and gain access to Trinity Biotech’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the healthcare services sector.
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 2